Yahoo FinanceArchived Aug 07, 2026✓ Full text saved
Cellebrite DI Ltd. Q1 2026 Earnings Call Summary Yahoo Finance
Full text archived locally
✦ AI Summary· Claude Sonnet
Cellebrite DI Ltd. Q1 2026 Earnings Call Summary
Moby Intelligence
May 15, 2026 3 min read
CLBT
-1.15%
Strategic Performance and Market Dynamics
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Performance was driven by a stabilization in sequential ARR growth and a shifting mix toward growth products, which now include Guardian, Pathfinder, and Drone Forensics.
Management attributes the successful quarter to the conversion of AI promises into tangible products, specifically the launch of Genesis, which addresses the 'explosion' in digital evidence volume.
The company is pivoting from a point-product vendor to a platform provider, integrating access, extraction, and AI-driven analysis into a unified workflow for law enforcement and intelligence agencies.
Strategic positioning in the U.S. Federal market has improved due to the stabilization of agency leadership and new appropriations specifically targeted at digital evidence management and fentanyl crisis response.
Operational resilience was highlighted by the Israeli team's ability to maintain performance despite heightened regional conflict and military actions.
The acquisition of SCG and the pending Corellium deal are central to expanding the TAM into prevention, intelligence, and drone forensics.
Outlook and Strategic Assumptions
Management estimates a $12.5 billion TAM for Investigative AI over the next four years, suggesting an opportunity to double the company's current total revenue through strong execution.
The Q2 guidance assumes a significant step-up in net new ARR, driven by a full quarter of availability for Advanced Unlocks and the mid-June general availability of Genesis.
The 2026 financial plan originally assumed zero AI-specific revenue, but management now expects material contributions following high early adopter interest.
U.S. Federal growth is expected to return to the 20% range, with potential to exceed historical mid-20s rates based on large-scale strategic initiatives and the new FedRAMP High authorization.
The transition to cloud and AI products is expected to lead to more ratable revenue recognition and improved long-term margin profiles.
Strategic Milestones and Risk Factors
Achieved FedRAMP High Level 4 authorization, a stringent security certification held by fewer than 100 companies, opening access to sensitive U.S. Department of Justice cloud contracts.
The Corellium acquisition remains pending CFIUS approval, representing a key component of the company's intelligence and vulnerability research strategy.
Management flagged FX headwinds as a roughly 2-point impact on adjusted EBITDA margins for the upcoming quarter.
Announced a leadership transition in the Product and Technology organization, with Shiv Ramji succeeding the retiring Ronen Arman to focus on security, AI, and cloud scaling.
Story Continues
View Comments
Terms and Privacy Policy
Privacy Dashboard